Melissa Hadley Barrett discusses real-world outcomes and tolerability of intranasal vardenafil for men with persistent erectile dysfunction despite prior standard therapy.
|Videos|June 17, 2022
Study explores relationship between testosterone and frailty in the operative setting
Author(s)Urology Times staff
Advertisement
In this video, Joshua Halpern, MD, discusses the abstract, “Association of low testosterone and frailty among veterans undergoing cancer surgery,” which he presented at the 2022 AUA Annual Meeting. Halpern is an assistant professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Advertisement
Related to this article
Juan J. Andino, MD, MBA, discusses surgical decision-making in prolonged ischemic priapism and how ischemia duration affects erectile dysfunction risk and treatment timing.
Abraham Morgentaler, MD, reviews evidence showing no association between testosterone therapy and prostate cancer risk and explains the saturation model of androgen action.
Advertisement
Advertisement
Trending on Urology Times
1
How PSMA-PET shapes staging and recurrence workup in prostate cancer
2
ESMO 2026: Key presentations across genitourinary oncology
3
Darolutamide associated with less cognitive change than enzalutamide in prostate cancer
4
European Commission approves perioperative pembrolizumab plus enfortumab vedotin for MIBC
5